Uroscopy in the 21st century: High-field NMR spectroscopy

Nephrology Dialysis Transplantation

Volumn 12, Issue 3, 1997, Pages 404-417

  Neild, G H ^a,c   Foxall, P J D ^a,b   Lindon, J C ^b   Holmes, E C ^b   Nicholson, J K ^b  

^a INSTITUTE OF UROLOGY AND NEPHROLOGY   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Kidney; NMR; Renal; Spectroscopy; Urine

Indexed keywords

CYST FLUID; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY POLYCYSTIC DISEASE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; UREMIA; UROGENITAL ENDOSCOPY;

FORECASTING; HUMANS; KIDNEY; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 0031049246     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.3.404     Document Type: Review

References (37)

1. Neild GH. William Cruickshank: Clinical Chemist. Nephrol Dial Transplant 1996; 11: 1885-1889
2. Smith ICP, Blandford DE. Nuclear magnetic resonance spectroscopy. Anal Chem 1995; 67: 509R-518R
3. Nicholson JK, Wilson ID. High resolution proton NMR spectroscopy of biological fluids. Progr NMR Spectrosc 1989; 21: 449-501
4. Videen JS, Ross BD. Proton nuclear magnetic resonance urinalysis: coming of age. Kidney Int 1994; 47: S-122-S-128
5. Bock JL. NMR in clinical chemistry - where do we stand? [Editorial]. Clin Chem 1994; 40: 1215-1217
6. Guenther H. NMR Spectroscopy. 2nd edn.: J. Wiley & Sons, Chichester, UK, 1995
7. 1H-13C NMR spectroscopy of human blood plasma. Anal Chem 1995; 67: 793-811
8. 1H-FT-NMR spectrometry. Eur J Pediatr 1986; 145: 260-266
9. Iles RA, Chalmers RA. Nuclear magnetic resonance spectroscopy in the study of inborn errors of metabolism. Clin Sci 1988; 74: 1-10
10. Ghauri FY, Parkes HG, Nicholson JK, Wilson ID, Brenton DP. Asymptomatic 5-oxoprolinuria detected by proton magnetic resonance spectroscopy. Clin Chem 1993; 39: 1341
11. 1H nuclear magnetic resonance spectra of human urine from normal and pathological states. Anal Biochem 1994; 220: 284-296
12. Nicholson JK, Timbrell JA, Sadler PJ, Proton NMR spectra of urine as indicators of renal damage. Mercury-induced nephrotoxicity in rats. Mol Pharmacol 1985; 27: 644-651
13. Gartland KPR, Bonner FW, Nicholson JK. Investigations into the biochemical effects of region-specific nephrotoxins. Mol Pharmacol 1989; 35: 242-250
14. Anthony ML, Gartland KP, Beddell CR, Lindon JC, Nicholson JK. Cephaloridine-induced nephrotoxicity in the Fischer 344 rat: proton NMR spectroscopic studies of urine and plasma in relation to conventional clinical chemical and histopathological assessments of nephronal damage. Arch Toxicol 1992; 66: 525-537
15. Anthony ML, Gartland KP, Beddell CR, Lindon JC, Nicholson JK. Studies of the biochemical toxicology of uranyl nitrate in the rat. Arch Toxicol 1994; 68: 43-53
16. Holmes E, Bonner FW, Sweatmen BC et al. NMR spectroscopy and pattern recognition analysis of the biochemical processes associated with the progression and recovery from nephrotoxic lesions on the rat induced by mercury II chloride and 2-bromoethanamine. Mol Pharmacol 1992; 42: 922-930
17. 2H NMR spectroscopic studies on the metabolism and biochemical effects of 2-bromoethanamine in the rat. Biochem Pharmacol 1995; 49: 1349-1359
18. Holmes E, Bonner FW, Gartland KP, Nicholson JK. Proton NMR monitoring of the onset and recovery of experimental renal damage. J Pharm Biomed Anal 1990; 8: 959-962
19. 1H NMR spectra of urine. A nonlinear mapping approach to the classification of toxicological data. NMR Biomed 1990; 3: 166-172
20. Gartland KP, Beddell CR, Lindon JC, Nicholson JK. Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine. Mol Pharmacol 1991; 39: 629-642
21. Holmes E, Nicholson JK, Bonner FW et al. Mapping the biochemical trajectory of nephrotoxicity by pattern recognition of NMR urinanalysis. NMR Biomed 1992; 5: 368-372
22. Spraul M, Neidig P, Klauck U et al. Automatic reduction of NMR spectroscopic data for statistical and pattern recognition classification of samples. J Pharm Biomed Anal 1994; 12: 1215-1225
23. Foxall PJD, Bending MR, Gartland KPR, Nicholson JK. Acute renal failure following accidental cutaneous absorption of phenol: application of proton NMR urinalysis to monitor the disease process. Hum Toxicol 1989; 9: 491-496
24. Foxall PJD, Lenz EM, Neild GH, Lindon JC, Wilson ID, Nicholson JK. NMR and HPLC-NMR studies on the toxicity and metabolism of ifosfamide. Ther Drug Monit 1996; 18: 498-505
25. Gilard V, Malet-Martino MC, de-Forni M, Niemeyer U, Ader JC, Martino R. Determination of the urinary excretion of ifosfamide and its phosphorated metabolites by phosphorus-31 nuclear magnetic resonance spectroscopy. Cancer Chemother Pharmacol 1993; 31: 387-94
26. 1H NMR urinalysis in glomerulonephritis: a new prognostic criterion. Magn Reson Imaging 1992; 10: 127-134
27. 1H-NMR urinalysis. Clin Chim Acta 1993; 214: 165-173
28. Foxall PJD, Mellotte GJ, Bending MR, Lindon JC, Nicholson JK. NMR spectroscopy as a novel approach to the monitoring of renal transplant function. Kidney Int 1993; 43: 234-245
29. Le Moyec L, Pruna A, Eugene M et al. Proton nuclear magnetic resonance spectroscopy of urine and plasma in renal transplantation follow-up. Nephron 1993; 65: 433-439
30. Foxall PJD, Bewley S, Neild GH, Rodeck CH, Nicholson JK. Analysis of fetal and neonatal urine using proton nuclear magnetic resonance spectroscopy. Arch Dis Child 1995; 73: F153-F157
31. Foxall PJD, Bewley S, Kingdom JCP, Rodeck CH, Neild GH, Nicholson JK. The effect of gestational age on the urinary excretion of organic osmolytes(Abstract). J Am Soc Nephrol 1995; 6: 361
32. Eugene M, Muller F, Dommergues M, Le Moyec L, Dumez Y. Evaluation of postnatal renal function in fetuses with bilateral obstructive uropathies by proton nuclear magnetic resonance spectroscopy. Am J Obstet Gynecol 1994; 170: 595-602
33. Bock JL. Metabolic profiling of amniotic fluid by proton nuclear magnetic resonance spectroscopy: correlation with fetal maturation and other clinical variables. Clin Chem 1994; 40: 56-61
34. Foxall PJD, Price RG, Jones JK, Neild GH, Thompson FD, Nicholson JK. High resolution proton magnetic resonance spectroscopy of cyst fluids from patients with polycystic kidney disease. Biochim Biophys Acta 1992; 1138: 305-314
35. 1H NMR spectroscopy of human blood plasma. J Pharm Biomed Anal 1993; 11: 267-276
36. Noronha-Dutra A, Epperlein M, Foxall P, Neild GH, Nicholson JK. Generation of formic acid during bicarbonate haemodialysis (Abstract). J Am Soc Nephrol 1993; 4: 373
37. Foxall PJD, Brown SM, Crowe A, Neild GH, Nicholson JK. 750 MHz NMR investigations into the effect of dialysis on the biochemical composition of uremic plasma (Abstract). J Am Soc Nephrol 1993; 4: 768